CTOs on the Move

St. Luke's Episcopal Health System

www.sleh.com

 
Saint Luke's Hospital of Kansas City is a 582-bed tertiary care hospital offering many specialized programs and services, with a network of 550 physicians practicing in more than 56 medical specialties.
  • Number of Employees: 0-25
  • Annual Revenue: > $1 Billion
  • www.sleh.com
  • 6624 Fannin St Ste 1100
    Houston, TX USA 77030-2323
  • Phone: 832.355.1000

Executives

Name Title Contact Details

Similar Companies

Lincoln Lutheran

Lincoln Lutheran is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Lincoln Lutheran is based in Racine, WI. You can find more information on Lincoln Lutheran at www.llor.org

RADIAS Health

Radias Health is a non-profit agency that provides mental health and substance use disorder services to adults in the Twin Cities metro area. Their services range from forensic evaluations to therapy, case management, housing, referrals, and medication...

Kentucky Clinical Research

Kentucky Clinical Research is a Grayson, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ruby Valley Hospital

Ruby Valley Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sheridan, MT. To find more information about Ruby Valley Hospital, please visit www.rubyvalleyhospital.com

Hemispherx Biopharma

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Its products include Ampligen, which is under clinical development for the treatment of Chronic Fatigue Syndrome, Hepatitis B, human immunodeficiency virus (HIV), renal cell carcinoma, and malignant melanoma; Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, a low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza and other emerging viral diseases. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.